… include p53 peptides, viral vectors, and dendritic cells pulsed … Under cellular stress, p53
becomes activated and stabilized to … p53- and PADRE-peptide–pulsed autologous DCs. Before …

… neoantigen peptide-pulsed autologous DC vaccine and … The number of mutations in the
TP53 gene ranks at the top, … Eventually, the Neo-DCVac stabilized the patient’s condition …

… targets for the development of anticancer vaccines. DC-based anticancer vaccination relies
on patient-derived DCs pulsed with a source of tumor-associated antigens (TAAs) in the …

… vaccines were continued until progressive disease (PD) was determined by immune-related
(… of HLA-A2 or A24 peptide-pulsed α-type-1 polarizing DC vaccines for the treatment of high-…

… involves the use of tumor vaccines made from autologous or … to electroporate immature
dendritic cells for subsequent co-… disulfide bridge for improved stabilization. When compared to …

… II trial of the p53 peptide cancer vaccine and DC vaccine (16)… response (PR), disease
stabilization, and prolonged survival … -associated antigens used to load dendritic cell vaccines. …

… modulate dendritic cell homeostasis [121, 122]. A phase I clinical trial of RNF43 peptide-pulsed …
The combination showed reduced tumor burden and long-term disease stability without …

… new ones) and stabilization of disease were usually reported in … dendritic cell injection
sites, flu-like symptoms (fever, chills, headache, and myalgia) and fatigue. These immune-related …

… T cell therapy with Nivolumab and NY-ESO-1 peptide-pulsed … p53-DC) used in this study is
obtained by the insertion of the … and CD8 + T cells, leading to disease stabilization in most of …

… Immunotherapy using dendritic cell-based vaccination is a natural approach using the …
outcomes and address the challenges associated with dendritic cell vaccination. Neoantigens are …